ldentification of genomic variants of the SARS-CoV-2 Virus in patients admitted to a reference hospital in Curitiba/PR and the relationship with the clinical condition
Maria Cecilia Neves Estephani, Laura Dos Anjos Bastos, Naiara Bozza Pegoraro, Eduardo Bolicenha Simm, João Otavio Ribas Zahdi, Maria Regina Pinheiro de Andrade Tizzot, Jaqueline Carvalho de Oliveira, Camila Nemetz Kohler, Liya Regina Mikami
{"title":"ldentification of genomic variants of the SARS-CoV-2 Virus in patients admitted to a reference hospital in Curitiba/PR and the relationship with the clinical condition","authors":"Maria Cecilia Neves Estephani, Laura Dos Anjos Bastos, Naiara Bozza Pegoraro, Eduardo Bolicenha Simm, João Otavio Ribas Zahdi, Maria Regina Pinheiro de Andrade Tizzot, Jaqueline Carvalho de Oliveira, Camila Nemetz Kohler, Liya Regina Mikami","doi":"10.5935/2238-3182.2022e33113-en","DOIUrl":null,"url":null,"abstract":"Mackenzie (HUEM), and to correlate the viral genetic variant and the presented symptoms with the development of the patient's clinical condition. Methods: A cross-sectional prospective study was performed with nasal swab samples from 219 SARS-CoV-2 positive patients. The patients were over 18 years old and were admitted to the HUEM between November 2021 and June 2022 for virus genotyping and analysis of medical records. Results: Of the 219 study participants, 66% had the delta variant and 33% had the omicron variant. The data obtained from deaths did not show significant relevance among the analyzed variables. The mean age was 61 years old, and the omicron variant affected older patients (65.5 years). The most prevalent comorbidities were SAH and DM in both genders, and the most relevant symptom was cough, which was observed mainly in those infected with the delta variant. Among the prognostic predictors, ground glass opacity on chest computed tomography was significantly more present in infections with delta variant. Conclusion: Delta variant affects the respiratory system more than omicron. In addition, despite of being collected in a similar time interval, the delta variant represented twice as many cases, which could demonstrate the effectiveness of the vaccine.","PeriodicalId":498063,"journal":{"name":"Revista Médica de Minas Gerais","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Médica de Minas Gerais","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/2238-3182.2022e33113-en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Mackenzie (HUEM), and to correlate the viral genetic variant and the presented symptoms with the development of the patient's clinical condition. Methods: A cross-sectional prospective study was performed with nasal swab samples from 219 SARS-CoV-2 positive patients. The patients were over 18 years old and were admitted to the HUEM between November 2021 and June 2022 for virus genotyping and analysis of medical records. Results: Of the 219 study participants, 66% had the delta variant and 33% had the omicron variant. The data obtained from deaths did not show significant relevance among the analyzed variables. The mean age was 61 years old, and the omicron variant affected older patients (65.5 years). The most prevalent comorbidities were SAH and DM in both genders, and the most relevant symptom was cough, which was observed mainly in those infected with the delta variant. Among the prognostic predictors, ground glass opacity on chest computed tomography was significantly more present in infections with delta variant. Conclusion: Delta variant affects the respiratory system more than omicron. In addition, despite of being collected in a similar time interval, the delta variant represented twice as many cases, which could demonstrate the effectiveness of the vaccine.